Crossmark

Reactivation of low avidity tumor-specific CD8<sup>+</sup> T cells associates with immunotherapeutic efficacy of anti-PD-1

Crossref DOI link: https://doi.org/10.1136/jitc-2023-007114

Published Online: 2023-08-16

Published Print: 2023-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Sugiyarto, Gessa

Lau, Doreen https://orcid.org/0000-0002-7623-2401
Hill, Samuel Luke https://orcid.org/0000-0002-9590-2116
Arcia-Anaya, David https://orcid.org/0000-0002-9902-5819
Boulanger, Denise S M

Parkes, Eileen E https://orcid.org/0000-0002-7855-3698
James, Edward

Elliott, Tim
Funding

Funding for this research was provided by:

Worldwide Cancer Research (20-0229)

Cancer Research UK (A28279)
License Information

License valid from 2023-08-16